有効な治療法のない進行消化器がん患者に対するSVN-2B単独投与の第Ⅰ相臨床試験  [in Japanese] Phase I clinical study of Survivin-derived peptide vaccine for patients with advanced gastrointestinal cancers  [in Japanese]

Codes

• NII Article ID (NAID)

  40020774852

• NII NACSIS-CAT ID (NCID)

  AN00229472

• Text Lang

  JPN

• ISSN

  0288-7509

• NDL Article ID

  027212001

• NDL Call No.

  Z19-484

• Data Source

  NDL